Sumit Aggarwal - Jan 24, 2024 Form 4 Insider Report for Eloxx Pharmaceuticals, Inc. (ELOX)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Sumit Aggarwal
Stock symbol
ELOX
Transactions as of
Jan 24, 2024
Transactions value $
$0
Form type
4
Date filed
1/26/2024, 04:32 PM
Previous filing
Jan 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELOX Restricted Stock Units Award $0 +60K $0.00 60K Jan 24, 2024 Common Stock 60K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.